Servier

Candidate Targets Indication Partner Our Commercial
Rights
Discovery Preclinical IND-
enabling
Phase I Phase Ib/IIa
Servier 4 Programs n.d./n.d. Bispecific Immuno-Oncology U.S. for 2 bispecifics
Discovery Phase completed
Pre-Clinical Phase not started
IND-enabling Phase not started
Phase 1 not started
Phase 2 not started